Citation 151912

BHAT,KPL: LANTVIT,D: CHRISTOV,K: MEHTA,RG: MOON,RC: PEZZUTO,JM:. (2001). ESTROGENIC AND ANTIESTROGENIC PROPERTIES OF RESVERATROL IN MAMMARY TUMOR MODELS.. 61(20)

Citation Details

Title	ESTROGENIC AND ANTIESTROGENIC PROPERTIES OF RESVERATROL IN MAMMARY TUMOR MODELS.
Authors	BHAT,KPL: LANTVIT,D: CHRISTOV,K: MEHTA,RG: MOON,RC: PEZZUTO,JM:
Year	2001
Volume	61
Issue	20

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LUCIFERASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
2	LUCIFERASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
3	LUCIFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
4	LUCIFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
5	LUCIFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
6	LUCIFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
7	PROTEIN EXPRESSION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
8	PROTEIN EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
9	PROTEIN EXPRESSION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
10	PROTEIN EXPRESSION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
11	PROTEIN EXPRESSION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
12	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
13	PROTEIN EXPRESSION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
14	PROTEIN EXPRESSION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
15	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	RESVERATROL	ACTIVE

Show SPARQL Queries (1)